ImmunoTargets and Therapyhttps://www.dovepress.com/feed/journal/138New articles released by Dove Press for ImmunoTargets and Therapyen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press ImmunoTargets and TherapyImmunoTargets and Therapyhttps://www.dovepress.com/feed/journal/138https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140Role of Cytokines in Bone Diseases and Their Therapeutic Applicationhttps://www.dovepress.com/role-of-cytokines-in-bone-diseases-and-their-therapeutic-application-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 07 May 2026 04:10:00 +1200https://doi.org/10.2147/ITT.S604392Context-Dependent Survival Associations Between Interleukin-13 Expression and Immunotherapy in Advanced Solid Tumorshttps://www.dovepress.com/context-dependent-survival-associations-between-interleukin-13-express-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 04 May 2026 14:40:00 +1200https://doi.org/10.2147/ITT.S578703Tumor-Promoting Crosstalk of MMP11⁺ Fibroblasts and SPP1⁺ Macrophages Drive Poor Prognosis in Breast Cancer: Integrated Multi-Omics Analysishttps://www.dovepress.com/tumor-promoting-crosstalk-of-mmp11-fibroblasts-and-spp1-macrophages-dr-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyWed, 29 Apr 2026 16:50:00 +1200https://doi.org/10.2147/ITT.S564498RNA Sequencing Analyses and Validation of Immune-Related Genes in EBV-Specific Cytotoxic T Lymphocytes During Latent Infectionhttps://www.dovepress.com/rna-sequencing-analyses-and-validation-of-immune-related-genes-in-ebv--peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 27 Apr 2026 19:40:00 +1200https://doi.org/10.2147/ITT.S568661Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohorthttps://www.dovepress.com/blinatumomab-for-pediatric-high-risk-b-cell-precursor-acute-lymphoblas-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 23 Apr 2026 21:40:00 +1200https://doi.org/10.2147/ITT.S603087New Insights on IgA Nephropathy from the Perspective of Active Lesions and Systemic Inflammatory Responseshttps://www.dovepress.com/new-insights-on-iga-nephropathy-from-the-perspective-of-active-lesions-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 21 Apr 2026 02:30:00 +1200https://doi.org/10.2147/ITT.S585437Multi-Omics Analysis Reveals m7G Methylation-Related Genes May Be Involved in TGF-β Signaling-Mediated Anti-PD-L1 Response in Bladder Cancerhttps://www.dovepress.com/multi-omics-analysis-reveals-m7g-methylation-related-genes-may-be-invo-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 14 Apr 2026 17:45:00 +1200https://doi.org/10.2147/ITT.S583577Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine Modelhttps://www.dovepress.com/cryoablation-plus-immune-checkpoint-inhibitors-enhanced-dendritic-cell-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 07 Apr 2026 18:20:00 +1200https://doi.org/10.2147/ITT.S581990Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Managementhttps://www.dovepress.com/guillain-barr-syndrome-progress-in-diagnosis-biomarkers-neuroimaging-a-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 02 Apr 2026 19:20:00 +1300https://doi.org/10.2147/ITT.S390161Circulating miR-148a-3p Correlates with Inadequate Induction Response in Pediatric Hodgkin Lymphomahttps://www.dovepress.com/circulating-mir-148a-3p-correlates-with-inadequate-induction-response--peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyWed, 01 Apr 2026 04:30:00 +1300https://doi.org/10.2147/ITT.S577426Comparative Clinical and Electrophysiological Profiles of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes Mellitus: An Observational Studyhttps://www.dovepress.com/comparative-clinical-and-electrophysiological-profiles-of-chronic-infl-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 26 Mar 2026 05:40:00 +1300https://doi.org/10.2147/ITT.S592658Progress on Potential Therapeutic Targets for Sepsis-Related Cardiac Dysfunction: From Basic Research to Clinical Translationhttps://www.dovepress.com/progress-on-potential-therapeutic-targets-for-sepsis-related-cardiac-d-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapySat, 21 Mar 2026 04:35:00 +1300https://doi.org/10.2147/ITT.S580700Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiationhttps://www.dovepress.com/kasugamycin-inhibits-melanoma-lung-metastasis-and-chi3l1-driven-m2-lik-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 19 Mar 2026 23:50:00 +1300https://doi.org/10.2147/ITT.S563951The Role of PD-L1 in Lung Cancer: From Biology to Clinical Applicationhttps://www.dovepress.com/the-role-of-pd-l1-in-lung-cancer-from-biology-to-clinical-application-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 19 Mar 2026 03:05:00 +1300https://doi.org/10.2147/ITT.S591588NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosishttps://www.dovepress.com/nup85-as-a-pan-cancer-immune-biomarker-integrated-multi-omics-and-func-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 17 Mar 2026 18:30:00 +1300https://doi.org/10.2147/ITT.S541852The Conjugation of Antibodies to Heat Shock Protein 70 Activates Immune Responses Against Tumor Cellshttps://www.dovepress.com/the-conjugation-of-antibodies-to-heat-shock-protein-70-activates-immun-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 16 Mar 2026 17:55:00 +1300https://doi.org/10.2147/ITT.S565942Lymphoproliferation in Inborn Errors of Immunity: Mechanisms, Manifestations and Clinical Management, with a Focus on ALPIDhttps://www.dovepress.com/lymphoproliferation-in-inborn-errors-of-immunity-mechanisms-manifestat-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapySat, 07 Mar 2026 04:35:00 +1300https://doi.org/10.2147/ITT.S582718Recurrent Glioblastoma and the Tumor Immune Landscape: Emerging Immunotherapeutic Strategieshttps://www.dovepress.com/recurrent-glioblastoma-and-the-tumor-immune-landscape-emerging-immunot-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 05 Mar 2026 04:50:00 +1300https://doi.org/10.2147/ITT.S581012UVB Upregulates Inflammatory Cytokines in Rosacea Cell Model by Promoting the Expression of TRPVs and TLR2https://www.dovepress.com/uvb-upregulates-inflammatory-cytokines-in-rosacea-cell-model-by-promot-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyWed, 04 Mar 2026 05:55:00 +1300https://doi.org/10.2147/ITT.S571037Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functionshttps://www.dovepress.com/targeting-sting-signalling-polarizes-tumor-associated-neutrophils-to-b-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 19 Feb 2026 20:15:00 +1300https://doi.org/10.2147/ITT.S576457The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisonshttps://www.dovepress.com/the-comparative-effectiveness-of-enlonstobart-and-camrelizumab-as-seco-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 19 Feb 2026 20:10:00 +1300https://doi.org/10.2147/ITT.S572970The Dual Mechanism of Action of CO-005 Overcomes CD20 Resistance in Diffuse Large B-Cell Lymphomahttps://www.dovepress.com/the-dual-mechanism-of-action-of-co-005-overcomes-cd20-resistance-in-di-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 19 Feb 2026 20:05:00 +1300https://doi.org/10.2147/ITT.S572396Immune Microenvironment of Hair Follicles in Tumor Immunotherapyhttps://www.dovepress.com/immune-microenvironment-of-hair-follicles-in-tumor-immunotherapy-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 16 Feb 2026 20:40:00 +1300https://doi.org/10.2147/ITT.S554731Recent Advances in Vitiligo Treatmenthttps://www.dovepress.com/recent-advances-in-vitiligo-treatment-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyWed, 11 Feb 2026 00:00:00 +1300https://doi.org/10.2147/ITT.S577653Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)https://www.dovepress.com/enhancing-nk-cell-activity-in-colorectal-cancer-with-an-fc-optimized-a-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 10 Feb 2026 01:35:00 +1300https://doi.org/10.2147/ITT.S533342A Novel Prognostic Signature Composed of Autophagy and Liver Metastasis in Colorectal Cancer: Comprehensive Analysis of Bulk and Single-Cell Transcriptomic Datahttps://www.dovepress.com/a-novel-prognostic-signature-composed-of-autophagy-and-liver-metastasi-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyFri, 06 Feb 2026 00:00:00 +1300https://doi.org/10.2147/ITT.S563779Enhancing Anti-CTLA-4 Antibody Delivery to the Brain Using Focused Ultrasound and Microbubbleshttps://www.dovepress.com/enhancing-anti-ctla-4-antibody-delivery-to-the-brain-using-focused-ult-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 02 Feb 2026 00:00:00 +1300https://doi.org/10.2147/ITT.S569804Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disordershttps://www.dovepress.com/postural-orthostatic-tachycardia-syndrome-myalgic-encephalomyelitischr-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 02 Feb 2026 00:00:00 +1300https://doi.org/10.2147/ITT.S581262Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancerhttps://www.dovepress.com/emerging-predictive-biomarkers-of-immunotherapy-sensitivity-in-patient-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 02 Feb 2026 00:00:00 +1300https://doi.org/10.2147/ITT.S567238Upregulated BLM and RECQL4 in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisibhttps://www.dovepress.com/upregulated-blm-and-recql4-in-osteosarcoma-association-with-poor-progn-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 22 Jan 2026 00:00:00 +1300https://doi.org/10.2147/ITT.S569823